Episode Details

Rick Batycky, CEO of Nocion Therapeutics, joins The BioHub Podcast by Avetix to discuss the company’s work in chronic cough and neurogenic inflammation.

Rick talks about the scale of the unmet need in chronic cough, why the condition remains so difficult to treat, and how Nocion is approaching the biology differently. He also shares insight into the company’s lead programme, its upcoming pivotal-stage development, and what successful execution could mean for patients who currently have limited treatment options.

The conversation also explores Rick’s perspective on building a focused biotech, operating as a lean virtual organisation, working with regulators, and leading a team through late-stage clinical development.